stockrowADC Therapeutics SA (ADCT) vs Akebia Therapeutics, Inc. (AKBA)
- ADC Therapeutics SA ADCT 1.66 −3.49%
- Akebia Therapeutics, Inc. AKBA 0.43 −37.68%
ADC Therapeutics SA and Akebia Therapeutics, Inc. are both Drug Manufacturers Specialty & Generic companies. ADC Therapeutics SA is the larger, with a market value of $209.4M against $117.9M — 1.8× the size. ADC Therapeutics SA grew revenue faster over the last twelve months: 3.03% against −12.4%. Akebia Therapeutics, Inc. has the higher net margin (−22.6% vs −121.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Akebia Therapeutics, Inc. leads on 10 and ADC Therapeutics SA on 6.
Valuation
Profitability
| Metric | ADCT | AKBA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 88.86% | 78.90% | 53.51% |
| Operating margin | (125.08%) | (15.74%) | 0.00% |
| Net margin | (121.77%) | (22.60%) | (2.45%) |
| Free cash flow margin | (127.72%) | 7.03% | 0.00% |
| Return on equity | 45.35% | (143.83%) | (0.80%) |
| Return on assets | (32.25%) | (12.62%) | (1.67%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack